Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR‐AKT‐mTOR signaling.

MLA

Lee, Kang‐Yun, et al. “Elevation of CD109 Promotes Metastasis and Drug Resistance in Lung Cancer via Activation of EGFR‐AKT‐mTOR Signaling.” Cancer Science, vol. 111, no. 5, May 2020, pp. 1652–62. EBSCOhost, https://doi.org/10.1111/cas.14373.

APA

Lee, K., Shueng, P., Chou, C., Lin, B., Lin, M., Kuo, D., Tsai, I., Wu, S., & Lin, C. (2020). Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR‐AKT‐mTOR signaling. Cancer Science, 111(5), 1652–1662. https://doi.org/10.1111/cas.14373

Chicago

Lee, Kang‐Yun, Pei‐Wei Shueng, Chih‐Ming Chou, Bo‐Xing Lin, Mei‐Hsiang Lin, Deng‐Yu Kuo, I‐Lin Tsai, Sheng‐Ming Wu, and Cheng‐Wei Lin. 2020. “Elevation of CD109 Promotes Metastasis and Drug Resistance in Lung Cancer via Activation of EGFR‐AKT‐mTOR Signaling.” Cancer Science 111 (5): 1652–62. doi:10.1111/cas.14373.